Skip to content
Skip to navigation menu

News archive for Cardiff Institute of Infection & Immunity

  • "Doctor Who" Christmas Special features Cardiff University equipment www.facebook.com25th December 2014The Cardiff Institute of Infection & Immunity and the Cardiff China Medical Research Collaborative donate laboratory equipment that features prominently in the "Last Christmas" episode aired on BBC1 on 25 December 2014.
  • Bridging the gap between immune disorder and mental illness 22nd December 2014Cardiff is among a group of UK Universities teaming up with researchers from two pharmaceutical companies to investigate whether mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer’s, could be treated by targeting the immune system.
  • Infection & Immunity Annual Meeting 2014 9th December 2014Cardiff scientists gathered at the Millennium Centre for the 3rd annual meeting of the Institute of Infection and Immunity
  • Celebrating Excellence Award for Ruth Williams 20th November 2014Ruth Williams from the Dermatology Department in the Cardiff Institute of Infection & Immunity receives the Celebrating Excellence Award 2014 for "Outstanding Contribution to Equality and Diversity”
  • New hope for halting cell death caused by disease 17th November 2014Scientists have discovered mechanisms that control a new form of premature cell death in living tissue - called ferroptosis - and a mechanism to reverse it.
  • PhD news: Dr Matt Morgan 11th November 2014Congratulations to clinical intensivist Matt Morgan on the successful defence of his PhD thesis entitled "Immune fingerprinting in acute severe sepsis".
  • NISCHR health fellowship awarded to Dr John Ingram 24th October 2014Dr Ingram was recently awarded a 5-year fellowship by the National Institute for Social Care and Health Research (NISCHR) to investigate hidradenitis suppurativa.
  • Diagnostic tool for leading viral cause of birth defects 15th October 2014Researchers from Cardiff and Swansea Universities have been awarded a grant of more than £323k to develop a new, non-invasive, low-cost, and easy to use point of care device to diagnose Human Cytomegalovirus (HCMV).